Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.

Levine AP, Chan MMY, Sadeghi-Alavijeh O, Wong EKS, Cook HT, Ashford S, Carss K, Christian MT, Hall M, Harris CL, McAlinden P, Marchbank KJ, Marks SD, Maxwell H, Megy K, Penkett CJ, Mozere M, Stirrups KE, Tuna S, Wessels J, Whitehorn D; MPGN/DDD/C3 Glomerulopathy Rare Disease Group; NIHR BioResource, Johnson SA, Gale DP.

J Am Soc Nephrol. 2020 Jan 9. pii: ASN.2019040433. doi: 10.1681/ASN.2019040433. [Epub ahead of print]

PMID:
31919107
2.

Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension.

Hodgson J, Swietlik EM, Salmon RM, Hadinnapola C, Nikolic I, Wharton J, Guo J, Liley J, Haimel M, Bleda M, Southgate L, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, Lawrie A, MacKenzie Ross RV, Moledina S, Montani D, Olschewski A, Olschewski H, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Suntharalingam J, Toshner MR, Trembath RC, Vonk Noordegraaf A, Wort SJ, Wilkins MR, Yu PB, Li W, Gräf S, Upton PD, Morrell NW.

Am J Respir Crit Care Med. 2019 Oct 29. doi: 10.1164/rccm.201906-1141OC. [Epub ahead of print]

PMID:
31661308
3.

Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia.

Bariana TK, Labarque V, Heremans J, Thys C, De Reys M, Greene D, Jenkins B, Grassi L, Seyres D, Burden F, Whitehorn D, Shamardina O, Papadia S, Gomez K, BioResource N, Van Geet C, Koulman A, Ouwehand WH, Ghevaert C, Frontini M, Turro E, Freson K.

Haematologica. 2019 May;104(5):1036-1045. doi: 10.3324/haematol.2018.204784. Epub 2018 Nov 22.

4.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

5.

Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.

Tuijnenburg P, Lango Allen H, Burns SO, Greene D, Jansen MH, Staples E, Stephens J, Carss KJ, Biasci D, Baxendale H, Thomas M, Chandra A, Kiani-Alikhan S, Longhurst HJ, Seneviratne SL, Oksenhendler E, Simeoni I, de Bree GJ, Tool ATJ, van Leeuwen EMM, Ebberink EHTM, Meijer AB, Tuna S, Whitehorn D, Brown M, Turro E, Thrasher AJ, Smith KGC, Thaventhiran JE, Kuijpers TW; NIHR BioResource–Rare Diseases Consortium.

J Allergy Clin Immunol. 2018 Oct;142(4):1285-1296. doi: 10.1016/j.jaci.2018.01.039. Epub 2018 Mar 2.

6.

A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.

Simeoni I, Stephens JC, Hu F, Deevi SV, Megy K, Bariana TK, Lentaigne C, Schulman S, Sivapalaratnam S, Vries MJ, Westbury SK, Greene D, Papadia S, Alessi MC, Attwood AP, Ballmaier M, Baynam G, Bermejo E, Bertoli M, Bray PF, Bury L, Cattaneo M, Collins P, Daugherty LC, Favier R, French DL, Furie B, Gattens M, Germeshausen M, Ghevaert C, Goodeve AC, Guerrero JA, Hampshire DJ, Hart DP, Heemskerk JW, Henskens YM, Hill M, Hogg N, Jolley JD, Kahr WH, Kelly AM, Kerr R, Kostadima M, Kunishima S, Lambert MP, Liesner R, López JA, Mapeta RP, Mathias M, Millar CM, Nathwani A, Neerman-Arbez M, Nurden AT, Nurden P, Othman M, Peerlinck K, Perry DJ, Poudel P, Reitsma P, Rondina MT, Smethurst PA, Stevenson W, Szkotak A, Tuna S, van Geet C, Whitehorn D, Wilcox DA, Zhang B, Revel-Vilk S, Gresele P, Bellissimo DB, Penkett CJ, Laffan MA, Mumford AD, Rendon A, Gomez K, Freson K, Ouwehand WH, Turro E.

Blood. 2016 Jun 9;127(23):2791-803. doi: 10.1182/blood-2015-12-688267. Epub 2016 Apr 15.

7.

A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.

Turro E, Greene D, Wijgaerts A, Thys C, Lentaigne C, Bariana TK, Westbury SK, Kelly AM, Selleslag D, Stephens JC, Papadia S, Simeoni I, Penkett CJ, Ashford S, Attwood A, Austin S, Bakchoul T, Collins P, Deevi SV, Favier R, Kostadima M, Lambert MP, Mathias M, Millar CM, Peerlinck K, Perry DJ, Schulman S, Whitehorn D, Wittevrongel C; BRIDGE-BPD Consortium, De Maeyer M, Rendon A, Gomez K, Erber WN, Mumford AD, Nurden P, Stirrups K, Bradley JR, Raymond FL, Laffan MA, Van Geet C, Richardson S, Freson K, Ouwehand WH.

Sci Transl Med. 2016 Mar 2;8(328):328ra30. doi: 10.1126/scitranslmed.aad7666. Epub 2016 Mar 2.

8.

An investigation of a possible relationship between olfactory identification deficits at first episode and four-year outcomes in patients with psychosis.

Good KP, Tibbo P, Milliken H, Whitehorn D, Alexiadis M, Robertson N, Kopala LC.

Schizophr Res. 2010 Dec;124(1-3):60-5. doi: 10.1016/j.schres.2010.07.010. Epub 2010 Aug 9.

PMID:
20692126
9.
10.

Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes.

Kopala LC, Good KP, Milliken H, Buiteman C, Woodley H, Rui Q, Whitehorn D, Love L, Balshaw R, Kiss I, Honer WG.

Schizophr Res. 2006 Jan 1;81(1):29-39. Epub 2005 Nov 2.

PMID:
16263246
11.

Hospitalization in the first year of treatment for schizophrenia.

Whitehorn D, Richard JC, Kopala LC.

Can J Psychiatry. 2004 Sep;49(9):635-8.

PMID:
15503737
12.

Quetiapine treatment in early psychosis: no evidence of cataracts.

Whitehorn D, Gallant J, Woodley H, Rui Q, Milliken H, Kopala L.

Schizophr Res. 2004 Dec 1;71(2-3):511-2. No abstract available.

PMID:
15474924
13.

The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients.

Good KP, Rabinowitz J, Whitehorn D, Harvey PD, DeSmedt G, Kopala LC.

Schizophr Res. 2004 May 1;68(1):11-9.

PMID:
15037335
14.

Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis.

Good KP, Kiss I, Buiteman C, Woodley H, Rui Q, Whitehorn D, Kopala L.

Br J Psychiatry Suppl. 2002 Sep;43:s45-9.

PMID:
12271800
15.

Neuromotor dysfunction in early psychosis.

Whitehorn D, Kopala LC.

Ann Clin Psychiatry. 2002 Jun;14(2):113-21. Review.

PMID:
12238736
16.

Prolactin elevation with quetiapine.

Alexiadis M, Whitehorn D, Woodley H, Kopala L.

Am J Psychiatry. 2002 Sep;159(9):1608-9. No abstract available.

PMID:
12202292
17.

Duration of untreated psychosis predicts treatment outcome in an early psychosis program.

Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC.

Schizophr Res. 2001 Mar 1;47(2-3):215-22.

PMID:
11278138
18.

Psychosocial rehabilitation early after the onset of psychosis.

Whitehorn D, Lazier L, Kopala L.

Psychiatr Serv. 1998 Sep;49(9):1135-7, 1147. No abstract available.

PMID:
9735953
19.

Towards an aggression-free health care environment.

Whitehorn D, Nowlan M.

Can Nurse. 1997 Mar;93(3):24-6. Review.

PMID:
9110634
20.

Age, sex and strain differences in activity and habituation in SHR and WKY rats.

Hendley ED, Wessel DJ, Atwater DG, Gellis J, Whitehorn D, Low WC.

Physiol Behav. 1985 Mar;34(3):379-83.

PMID:
4011719
21.
22.

Genetically related rats with differences in hippocampal uptake of norepinephrine and maze performance.

Low WC, Whitehorn D, Hendley ED.

Brain Res Bull. 1984 Jun;12(6):703-9.

PMID:
6478258
23.

Enhanced preganglionic sympathetic nerve responses in spontaneously hypertensive rats.

Morrison SF, Whitehorn D.

Brain Res. 1984 Mar 26;296(1):152-5.

PMID:
6713206
24.
25.

Locomotor activity, auditory startle and shock thresholds in spontaneously hypertensive rats.

Leaton RN, Cassella JV, Whitehorn D.

Physiol Behav. 1983 Jul;31(1):103-9.

PMID:
6634969
27.

Dissociation of genetic hyperactivity and hypertension in SHR.

Hendley ED, Atwater DG, Myers MM, Whitehorn D.

Hypertension. 1983 Mar-Apr;5(2):211-7.

PMID:
6681804
28.

Independence of blood pressure and locomotor hyperactivity in normotensive and genetically hypertensive rat.

Whitehorn D, Atwater DG, Low WC, Gellis JE, Hendley ED.

Behav Neural Biol. 1983 Mar;37(2):357-61.

PMID:
6194784
29.

Baroreceptor reflex gain is not diminished in spontaneous hypertension.

Morrison SF, Whitehorn D.

Am J Physiol. 1982 Nov;243(5):R500-5.

PMID:
7137379
30.

Cardiovascular responses elicited by electrical stimulation of the amygdala central nucleus in the rabbit.

Kapp BS, Gallagher M, Underwood MD, McNall CL, Whitehorn D.

Brain Res. 1982 Feb 25;234(2):251-62.

PMID:
7059829
31.
32.

An input-output analysis of the dorsal column nuclei.

Walsh JP, Whitehorn D.

Exp Neurol. 1981 Jul;73(1):186-98. No abstract available.

PMID:
7250273
33.

Frequency following and conduction speed as identifiers of major subsets among cuneothalamic neurons.

Walsh JP, Whitehorn D.

Exp Neurol. 1979 Apr;64(1):190-201. No abstract available.

PMID:
428495
34.

Effect of hypothalamic stimulation in spontaneously hypertensive and Wistar-Kyoto rats.

Juskevich JC, Robinson DS, Whitehorn D.

Eur J Pharmacol. 1978 Oct 15;51(4):429-39.

PMID:
710512
35.

Ascending collaterals of cutaneous neurons in the fasciculus gracilis of the cat.

Horch KW, Burgess PR, Whitehorn D.

Brain Res. 1976 Nov 19;117(1):1-17.

PMID:
990925
36.

Population analysis of single units in the cuneate nucleus of the cat.

Blum P, Bromberg MB, Whitehorn D.

Exp Neurol. 1975 Jul;48(1):57-78. No abstract available.

PMID:
1132469
37.

Quantitative characteristics of inhibition in the cuneate nucleus of the cat.

Bromberg MB, Blum P, Whitehorn D.

Exp Neurol. 1975 Jul;48(1):37-56. No abstract available.

PMID:
1132468
38.

Cutaneous receptors supplied by myelinated fibers in the cat. II. Number of mechanoreceptors excited by a local stimulus.

Burgess PR, Howe JF, Lessler MJ, Whitehorn D.

J Neurophysiol. 1974 Nov;37(6):1373-86. No abstract available.

PMID:
4436707
39.

Cutaneous receptors supplied by myelinated fibers in the cat. I. Number of receptors innervated by a single nerve.

Whitehorn D, Howe JF, Lessler MJ, Burgess PR.

J Neurophysiol. 1974 Nov;37(6):1361-72. No abstract available.

PMID:
4436706
40.

Myelinated fiber types in the superficial radial nerve of the cat and their central projections.

Bromberg MB, Whitehorn D.

Brain Res. 1974 Sep 20;78(1):157-63. No abstract available.

PMID:
4458912
41.

Impulse generation in type I cutaneous mechanoreceptors.

Horch KW, Whitehorn D, Burgess PR.

J Neurophysiol. 1974 Mar;37(2):267-81. No abstract available.

PMID:
4815205
42.

Polarization changes in the terminals of identified primary afferent fibers at the gracile nucleus.

Putnam JE, Whitehorn D.

Exp Neurol. 1973 Nov;41(2):246-59. No abstract available.

PMID:
4355645
43.
44.

Activation of gracile nucleus: time distribution of activity in presynaptic and postsynaptic elements.

Whitehorn D, Bromberg MB, Howe JF, Putnam JE, Burgess PR.

Exp Neurol. 1972 Nov;37(2):312-21. No abstract available.

PMID:
4637953
45.

Role of the spinocervical tract in production of the primary cortical response evoked by forepaw stimulation.

Whitehorn D, Morse RW, Towe AL.

Exp Neurol. 1969 Nov;25(3):349-64. No abstract available.

PMID:
5351342
46.

Inadequacy of graduate education.

Whitehorn D.

Physiologist. 1969 May;12(2):109-11. No abstract available.

PMID:
5789025
47.

Postsynaptic potential patterns evoked upon cells in sensorimotor cortex of cat by stimulation at the periphery.

Whitehorn D, Towe AL.

Exp Neurol. 1968 Oct;22(2):222-4. No abstract available.

PMID:
5724945
48.

Differential activity among wide-field neurons of the cat postcruciate cerebral cortex.

Towe AL, Whitehorn D, Nyquist JK.

Exp Neurol. 1968 Apr;20(4):497-521. No abstract available.

PMID:
5659444

Supplemental Content

Loading ...
Support Center